Contents
Contents
Private equity Medicaid fraud cases can reach an owner whose decisions help cause false claims for government health care payment. South Bay’s case put supervision warnings and the owner’s power to act at the center of that question. Ancor settled allegations that it learned about kickbacks before investing, then allowed them to continue while managing the company. For someone inside a clinic, billing office or investment firm, the connection is concrete: what care the company billed, what the owner knew, and what happened after the warning.
South Bay Mental Health Center’s case concerned alleged false Medicaid provider claims for care delivered by unlicensed, unqualified or improperly supervised staff. A staff-training coordinator brought the case, and Massachusetts joined it. In October 2021, the Massachusetts Attorney General announced a resolution in which a private equity firm and former South Bay executives agreed to pay $25 million.
The court’s May 2021 order explains how H.I.G. entered the case. Community Intervention Services and its holding company bought South Bay in 2012, with H.I.G. Growth Partners as the holding company’s majority shareholder. H.I.G. employees held most seats on the Community Intervention Services board.
Before the acquisition, a clinical expert’s diligence report sent to H.I.G. identified documentation problems and poor supervision, and recommended further training. South Bay’s outpatient mental health director later testified that pressure to grow increased sharply after the purchase. She described the operational problem: more clinical volume required more licensed supervisors.
An internal report in April 2014 found that 70 percent of South Bay’s supervisors were unlicensed. Community Intervention Services’ chief clinical officer sent that report to H.I.G. board members in 2016, saying it remained relevant. The court also described working groups called Tiger Teams, where employees said they raised the need for more independently licensed supervisors and circulated the MassHealth requirements. These were warnings about the qualifications behind Medicaid bills, reaching people with authority over the business.
A later leadership assessment supplied a particularly blunt staff account of what followed those working groups:
We were unwilling to spend the money after the Tiger Teams to implement the required changes. It was a thorough process, but nothing was implemented.
The defendants disputed whether the recommendations addressed regulatory compliance and whether they had gone unimplemented. We see the absurdity in that staff account: a thorough review, followed by no money for the changes it called for.
The court allowed the case against H.I.G. to continue because evidence connected its board power and knowledge to the alleged failure to correct South Bay’s billing practices. It pointed to evidence that H.I.G. understood the company relied on Medicaid revenue, knew payment carried conditions, received supervision warnings and had power through the board to address the violations.
The same order made a narrower finding about three actual claims. Each involved an unlicensed clinician supervised by another unlicensed clinician when the service occurred, with any licensed supervision months away from that service. The court held those claims false.
That gives an insider something more useful than an ownership chart. The clinician’s qualifications and supervision connect to the service date and the payment request. The warning and the decision afterward connect the billing problem to management. In South Bay, those connections gave the court a reason to examine the owner’s conduct.
South Bay received payment directly from MassHealth and through the Massachusetts Behavioral Health Partnership and other managed care organizations. Most of its clients were MassHealth members, and the court described MassHealth as ultimately responsible for payment whichever route administered their coverage.
Under Medicaid managed care, the state typically pays a plan a fixed periodic amount for each enrolled member. The provider’s bill sits further along that payment route. In South Bay, the court ruled that billing through a managed care plan still required compliance with MassHealth’s supervision rules. Whichever route the money took, the bill still depended on who supervised the session.
Benevis and more than 130 Kool Smiles clinics agreed to pay $23.9 million in the January 2018 settlement announced by the Justice Department. Benevis supplied business management and administrative services to the clinics.
The government alleged that, from January 2009 through December 2011, the clinics billed Medicaid for unnecessary baby root canals, extractions and stainless steel crowns, as well as baby root canals never performed. Its dental fraud allegations connected those procedures to production goals. According to the government, clinics disciplined dentists considered unproductive, paid substantial cash bonuses tied to procedure revenue and ignored their own dentists’ complaints about overuse.
The allegation puts the revenue target in the treatment chair. The government alleged that children underwent procedures they did not need while the clinics ignored warnings from their own dentists. Five whistleblower lawsuits initiated the government’s investigation. Among the whistleblowers receiving a share were former Kool Smiles employees.
FORBA Holdings, which managed Small Smiles clinics, had already settled unnecessary or deficient pediatric dental service allegations for $24 million in 2010. A June 2013 joint Senate staff report on corporate dentistry reproduced an investment memorandum explaining how FORBA ran clinics it did not own. Citing state restrictions on corporate dental practice, the memorandum said FORBA did not own the practices or employ their dentists. Yet it selected sites, negotiated leases, bought equipment, installed billing systems, employed staff, recruited dentists and received the income.
The same report described bonuses tied to productivity, patient volume and movement from hygiene services to better-paying operative work. That is why we look at management agreements alongside clinical records: they can explain who controlled the infrastructure and incentives around the treatment.
Ancor Holdings’ settlement expressly connected the investor to an alleged referral arrangement at Alliance Family of Companies, a provider of ambulatory EEG testing. In its July 2021 announcement, the Justice Department alleged that Ancor learned about kickbacks during diligence before investing, then allowed the conduct to continue after entering an agreement to manage Alliance.
The alleged provider kickbacks were free EEG interpretation reports supplied to referring physicians. According to the government, those reports let primary care physicians who were not neurologists bill as though they had interpreted the tests themselves. The government separately alleged that Alliance used an inaccurate code to obtain higher reimbursement and billed for specialized digital analysis it had not performed.
Alliance agreed to pay $13.5 million to resolve its allegations. Ancor separately agreed to pay $1,780,349 to the federal government and $64,369 to state Medicaid programs. We notice who paid the smaller check: the investor alleged to have known about the kickbacks before buying in. The settlement resolved six whistleblower cases.
We look for the link between what was billed, the service actually provided, the payment rule and the people who knew. In South Bay, that meant clinician credentials, supervision records and dates, alongside internal reports and board knowledge. The court said supervision records had to be truthful and treated blank supervision forms as inadequate documentation.
A 1999 report sponsored by the Health Care Financing Administration, Controlling Fraud and Abuse in Medicaid: Innovations and Obstacles, drew an enduring distinction. Its discussion of external validation focused on:
checking that the claim was true, rather than just billed properly and processed correctly.
The report also distinguished provider fraud against a managed care organization from fraud committed by the organization itself. For this page’s cases, the practical comparison stays with the billed service: the supervision behind the therapy, the clinical reason for the dental procedure or the person who actually interpreted the test. We connect that account with the bonus plan, warning or management decision that explains why the billing continued.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. If you saw the clinical problem and know who was told, you may hold the connection between the claim and the owner’s decision.
If you saw supervision concerns, treatment quotas or referral payments reach the owner’s desk, speak with our whistleblower experts about what happened next. We work with you to connect the healthcare billing to the people directing it and build a Medicaid whistleblower case around the decisions you witnessed. We bring in Medicaid fraud whistleblower lawyers who understand investor involvement and remain your partners throughout the case.